Allergies News and Research

Latest Allergies News and Research

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis, and middle-ear infections.

15 Dec 2020

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics.

15 Dec 2020

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

14 Dec 2020

Pre-existing immunity shapes a person's antibody response to influenza viruses

New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected.

11 Dec 2020

Combination of baricitinib and remdesivir could benefit some COVID-19 patients

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine.

11 Dec 2020

Researchers analyze prevalence of COVID-19 in human post-mortem ocular tissues

COVID-19 has been found in conjunctival swabs and tears of infected patients, according to a new study published in The Ocular Surface.

11 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

A team of immunologists from RUDN University suggested a new tool to control inflammation levels in asthma patients with accompanying diseases.

7 Dec 2020

Study offers hope to parents and kids who face real danger from peanut exposure

It's a peanut-filled world--or at least it can feel that way for kids with peanut allergies. But a new study by researchers at the University of British Columbia and BC Children's Hospital gives hope to parents and kids who face real danger from exposure to peanuts.

3 Dec 2020

International scientific team reports 'super-spreader' potential of Andes virus

"Super-spreader" events and extensive person-to-person contact propelled an outbreak of hantavirus pulmonary syndrome in a small village in Argentina from 2018-2019, according to research published today in The New England Journal of Medicine.

3 Dec 2020

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

3 Dec 2020

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.

3 Dec 2020

Researchers study SerpinB9 protein that could pave way to new immunotherapy approach

Immunotherapies have transformed the landscape of cancer treatment by allowing physicians to alter or augment patients' immune response to better attack malignant tumors.

2 Dec 2020

Nanomedicine's giant step into the fight against the COVID-19

A recent editorial in Nature Nanotechnology discusses the enormous feat of scientific innovation, with messenger RNA (mRNA)-based vaccines developed to deliver the gene sequence of specific SARS-CoV-2 viral proteins into host cells using nanotechnology platforms.

1 Dec 2020

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Researchers have published a study on the efficacy of steam inhalations as another possible treatment to help mitigate SARS-CoV-2 infection.

30 Nov 2020

Specific bacterium in the gut associated with IBS symptoms

Researchers at the University of Gothenburg have detected a connection between Brachyspira, a genus of bacteria in the intestines, and IBS -- especially the form that causes diarrhea.

25 Nov 2020

Allergies News and Research

Latest Allergies News and Research

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

Pediatricians want kids to be part of COVID vaccine trials

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

Pre-existing immunity shapes a person's antibody response to influenza viruses

Combination of baricitinib and remdesivir could benefit some COVID-19 patients

Researchers analyze prevalence of COVID-19 in human post-mortem ocular tissues

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

Study offers hope to parents and kids who face real danger from peanut exposure

International scientific team reports 'super-spreader' potential of Andes virus

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

Researchers study SerpinB9 protein that could pave way to new immunotherapy approach

Nanomedicine's giant step into the fight against the COVID-19

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Steam inhalation therapy found to inactivate SARS-CoV-2 virions

Specific bacterium in the gut associated with IBS symptoms

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in